These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21764277)

  • 41. Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.
    McKeage K
    Drugs; 2012 Mar; 72(4):543-63. PubMed ID: 22356291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
    Beeh KM; Beier J
    Adv Ther; 2009 Jul; 26(7):691-9. PubMed ID: 19609496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials.
    Wedzicha JA; Buhl R; Lawrence D; Young D
    Respir Med; 2015 Jan; 109(1):105-11. PubMed ID: 25433954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.
    Kerstjens HA; Deslée G; Dahl R; Donohue JF; Young D; Lawrence D; Kornmann O
    Pulm Pharmacol Ther; 2015 Jun; 32():101-8. PubMed ID: 25743376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular safety of QVA149, a combination of Indacaterol and NVA237, in COPD patients.
    Van de Maele B; Fabbri LM; Martin C; Horton R; Dolker M; Overend T
    COPD; 2010 Dec; 7(6):418-27. PubMed ID: 21166630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease.
    Matsushima S; Inui N; Yasui H; Kono M; Nakamura Y; Toyoshima M; Shirai T; Suda T
    Pulm Pharmacol Ther; 2015 Feb; 30():11-5. PubMed ID: 25445929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity.
    Mahler DA; Buhl R; Lawrence D; McBryan D
    Pulm Pharmacol Ther; 2013 Jun; 26(3):348-55. PubMed ID: 23434446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD.
    Worth H; Chung KF; Felser JM; Hu H; Rueegg P
    Respir Med; 2011 Apr; 105(4):571-9. PubMed ID: 21227674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design.
    Barnes PJ; Pocock SJ; Magnussen H; Iqbal A; Kramer B; Higgins M; Lawrence D
    Pulm Pharmacol Ther; 2010 Jun; 23(3):165-71. PubMed ID: 20080201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
    Earnshaw SR; Wilson MR; Dalal AA; Chambers MG; Jhingran P; Stanford R; Mapel DW
    Respir Med; 2009 Jan; 103(1):12-21. PubMed ID: 19010652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Indacaterol--a new hope for maximising bronchodilation?].
    Mihălţan F
    Pneumologia; 2011; 60(1):21-5. PubMed ID: 21548196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of indacaterol/glycopyrronium in comparison with salmeterol/fluticasone combination for patients with moderate-to-severe chronic obstructive pulmonary disease: a LANTERN population analysis from Singapore.
    Tee A; Chow WL; Burke C; Guruprasad B
    Singapore Med J; 2018 Jul; 59(7):383-389. PubMed ID: 29546433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of indacaterol with tiotropium or twice-daily long-acting β -agonists for stable COPD: a systematic review.
    Rodrigo GJ; Neffen H
    Chest; 2012 Nov; 142(5):1104-1110. PubMed ID: 22383666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD.
    Dalal AA; Petersen H; Simoni-Wastila L; Blanchette CM
    J Med Econ; 2009; 12(4):339-47. PubMed ID: 19827993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol.
    Cazzola M; Segreti A; Stirpe E; Puxeddu E; Ora J; Rogliani P; Matera MG
    Respir Med; 2013 Jan; 107(1):107-11. PubMed ID: 23083839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease.
    Oba Y
    Mayo Clin Proc; 2007 May; 82(5):575-82. PubMed ID: 17493425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic treatment with indacaterol and airway response to salbutamol in stable COPD.
    Cazzola M; Rogliani P; Ruggeri P; Segreti A; Proietto A; Picciolo S; Matera MG
    Respir Med; 2013 Jun; 107(6):848-53. PubMed ID: 23490225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bronchodilator effects of indacaterol and formoterol in patients with COPD.
    Beier J; Beeh KM; Brookman L; Peachey G; Hmissi A; Pascoe S
    Pulm Pharmacol Ther; 2009 Dec; 22(6):492-6. PubMed ID: 19465142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indacaterol once-daily is equally effective dosed in the evening or morning in COPD.
    Magnussen H; Verkindre C; Jack D; Jadayel D; Henley M; Woessner R; Higgins M; Kramer B;
    Respir Med; 2010 Dec; 104(12):1869-76. PubMed ID: 20850959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.